News
PREMIA and Lind Form Lind Asia to Expand AI-Powered Clinical Trial Screening Across Asia-Pacific
35+ min ago (278+ words) TAIPEI and SAN MATEO, Calif. , May 27, 2026 (GLOBE NEWSWIRE) -- Precision Medicine Asia, Limited (PREMIA) and Lind today announced the formation of Lind Asia, a strategic joint venture dedicated to revolutionizing clinical trial enrollment in the Asia-Pacific region. Lind Asia will serve…...
Tedopi Plus Pembrolizumab Improves Progression-Free Survival in Ovarian Cancer
9+ hour, 53+ min ago (101+ words) The Clinical Trial Vanguard Tedopi Plus Pembrolizumab Improves Progression-Free Survival in Ovarian Cancer A hazard ratio of 0. 53 against best supportive care sounds straightforward until you examine the baseline: median progression-free survival in the control arm was just 2. 8 months, reflecting a…...
Al-Ola A Abdallah Comments On the New Article on Dual-Target CAR-T Strikes Hard in EMD - Onco Daily
14+ hour ago (269+ words) Al-Ola A Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, shared a post on'X: "Dual-Target CAR-T Strikes Hard in EMD: ORR 97%, PFS 6 months! Is Persistence the Missing…...
One-time gene editing cuts LDL cholesterol in early hypercholesterolemia trial
13+ hour, 48+ min ago (483+ words) A single infusion of VERVE-102 sharply lowered PCSK9 and LDL cholesterol in a small phase 1 trial, offering early evidence for a potentially durable genetic approach to cholesterol control, while long-term safety and clinical benefit remain to be proven. Study: In Vivo…...
Eli Lilly Gene Therapy Cuts Cholesterol Dramatically in Early Trial
9+ hour, 59+ min ago (63+ words) Whalesbook Eli Lilly's gene-editing therapy VERVE-102 has shown impressive early results, cutting LDL-C by 62% and PCSK9 protein by 88% in a Phase 1b trial. This one-time treatment, acquired from Verve Therapeutics, aims to offer a permanent solution for high cholesterol patients, reducing the…...
Can an injection prevent heart attacks? Eli Lilly's gene-editing therapy cuts LDL cholesterol by 62%
14+ hour, 26+ min ago (279+ words) In an early-stage clinical trial, published in "The New England Journal of Medicine" and presented at the European Atherosclerosis Society Congress this week, researchers reported that a single infusion of a gene-editing therapy called VERVE-102 sharply lowered LDL cholesterol by…...
New Pill May Replace CPAP for People with Sleep Apnea
16+ hour, 22+ min ago (580+ words) ...
Vitamin D analog shuts down pancreatic cancer's shield in a clinical trial
20+ hour, 49+ min ago (14+ words) Medical Xpress...
From idea to impact: CS Innovation Seed Fund backs safer drug access for vets
23+ hour, 44+ min ago (689+ words) A locked box might not sound like a mental health tool. But for many vets, it could be part of saving lives. The fund supports a broad range of projects, including proofs of concept, spinout feasibility studies, new income-generating initiatives,…...
Bempedoic acid shows promise in lowering LDL-C. .. | Pluang " Crypto, Stocks, Gold & Funds
1+ day, 12+ hour ago (492+ words) Esperion Therapeutics presented new data at the 2026 European Atherosclerosis Society Congress showing bempedoic acid effectively lowers LDL cholesterol in children aged 6-17 with familial hypercholesterolemia and is well tolerated. A secondary analysis from the CLEAR Outcomes study also identified factors like…...